SCHEMBL1728196

SCHEMBL1728196

Cc1sc(NC(=O)c2ccc(S(=O)(=O)C3CCc4ccccc4N3)cc2)nc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 4/20 0.50
POLB P06746 1/20 0.50
SMN1; SMN2 Q16637 11/20 0.47
MAPT P10636 8/20 0.47
NPSR1 Q6W5P4 4/20 0.47
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
KMT2A Q03164 8/20 0.46
MEN1 O00255 6/20 0.46
HPGD P15428 6/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
ADORA3 P0DMS8 2/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
HTT P42858 2/20 0.45
PKM P14618 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1726841 0.82 PHGDH (0.60) LMNAALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1728185 0.82 MAPT (0.55) LMNAALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1726609 0.82 MAPT (0.54) LMNAALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL1727655 0.81 SMN1; SMN2 (0.59) LMNAALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL1728020 0.80 KMT2A (0.60) LMNAALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL1726674 0.78 NPC1 (0.52) LMNAPOLBSMN1; SMN2MAPTRAB9A
SCHEMBL1727944 0.78 LRRK2 (0.59) LMNAALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL17107156 0.77 ALDH1A1 (0.79) LMNAALDH1A1KDM4EPOLBSMN1; SMN2
SCHEMBL1728487 0.76 MEN1 (0.51) LMNAALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL1726833 0.76 KDM4A (0.60) LMNAALDH1A1KDM4ESMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403499-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL Stemsynergy Therapeutics, Inc (US) 2012-01-11 EP disclosed
WO-2010101964-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL STEMSYNERGY THERAPEUTICS, INC (US) 2010-09-10 WO disclosed